Hong Kong DengYue Medicine is an international pharmaceutical supply and healthcare resource integration company headquartered in Hong Kong. Based in Hong Kong, a global pharmaceutical trade and financial hub, the company serves the Asian and global markets, committed to building a compliant, efficient, and stable international pharmaceutical supply system, promoting the cross-border flow and accessibility of high-quality pharmaceuticals and healthcare resources.

I. Positioning and Business Focus

Hong Kong DengYue Medicine's long-term core businesses encompass:

● Targeted Oncology and Immunotherapy Drugs

● Covering various solid tumors and hematological malignancies, with a focus on innovative mechanism drugs and mature products with clear clinical value.

● Orphan Drugs

Focusing on disease areas with a small patient base but highly concentrated treatment needs, emphasizing drug quality, supply stability, and long-term accessibility.

● Neurological Treatments

Including neurodegenerative diseases and autoimmune-related neurological diseases, requiring extremely high levels of efficacy evidence and drug safety.

● Innovative Biologics and Specialty Drugs

Involving biologics, complex formulations, and specialty drugs with stringent cold chain and quality system requirements. The company integrates global high-quality pharmaceutical resources, manufacturing capabilities, and downstream healthcare needs to build an integrated service model covering drug selection, compliance access, international supply, and market support.

II. Compliance as the Bottom Line, Patient-Centered Approach

1. Compliance and Quality First

Dengyue Pharmaceutical always regards compliant operation and a quality system as the lifeline of its development. The company strictly follows mainstream international regulatory frameworks and quality standards (such as GMP, GDP, and related registration and import/export regulations), and continuously invests in supply chain management, documentation systems, cold chain logistics, and traceability management to ensure the safety, efficacy, and traceability of drugs throughout the entire distribution process.

2. Patient-Centered Approach

In areas such as rare diseases, oncology, and neurological disorders, patients often face limited treatment options, high medication costs, and difficulties in obtaining medications. Dengyue Pharmaceutical prioritizes "patient accessibility" as one of its core values, striving to shorten the distance between the production and clinical application of innovative and specialty drugs, while adhering to legal and compliant principles.

3. Long-Term Vision and Steady Development

The company adheres to a long-term vision, avoiding short-term arbitrage-driven growth. Instead, it establishes a sustainable international business network through stable partnerships, continuous compliance investment, and reliable supply capabilities. This philosophy enables Dengyue Pharmaceutical to maintain steady development in the complex and ever-changing global pharmaceutical environment.

III. International Vision and Resource Integration Capabilities

Leveraging Hong Kong's unique advantages in international trade, regulatory alignment, and financial services, Dengyue Pharmaceutical actively promotes:

● Cross-regional resource integration: Connecting manufacturing enterprises and healthcare systems in Mainland China, Asia, and other international markets.

● International registration and market access support: Assisting partners in understanding the regulatory requirements of different countries and regions.

● Stable supply and risk management: Addressing global pharmaceutical supply chain fluctuations and enhancing long-term delivery capabilities.

The company focuses not only on "whether drugs can enter the market," but also on "whether drugs can serve patients stably and sustainably in the long term."

IV. Corporate Mission and Vision

Mission: To promote the international circulation of high-quality pharmaceuticals on the basis of compliance and transparency, enabling more patients to access safe, effective, and sustainable treatment options.

Vision: To become a vital bridge connecting innovative drugs, high-quality manufacturing, and global healthcare needs, establishing a trustworthy international pharmaceutical cooperation platform in the fields of oncology, rare diseases, and specialty treatments.

In conclusion, against the backdrop of rising global healthcare costs, increasingly stringent regulatory requirements, and patients' growing demands for treatment quality and accessibility, Hong Kong DengYue Medicine is gradually evolving from a simple drug supplier into a comprehensive pharmaceutical resource integrator with compliance capabilities, professional judgment, and international collaboration.

By adhering to quality standards, focusing on high-value therapeutic areas, and promoting cross-border cooperation, DengYue Medicine is steadily participating in and witnessing the global pharmaceutical industry's development towards greater standardization, professionalism, and long-term value orientation.